Robert59
Well-known Member
The U.S. will pay nearly $2 billion for 100 million doses of a potential COVID-19 vaccine being developed by Pfizer and its German partner BioNTech.
Shares of the U.S. drugmaker jumped 5% about an hour before the opening bell.
The U.S. government will receive the doses and make the payment after the drugmakers receive regulatory approval for a potential vaccine that has yet to start big clinical trials in humans. It also can acquire up to an additional 500 million doses, according to a statement released Wednesday by the drugmakers.
https://finance.yahoo.com/news/feds-agree-buy-100-m-122822396.html
Shares of the U.S. drugmaker jumped 5% about an hour before the opening bell.
The U.S. government will receive the doses and make the payment after the drugmakers receive regulatory approval for a potential vaccine that has yet to start big clinical trials in humans. It also can acquire up to an additional 500 million doses, according to a statement released Wednesday by the drugmakers.
https://finance.yahoo.com/news/feds-agree-buy-100-m-122822396.html